Search Results - "Blunt, Danielle"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Erased: The impact of FOSTA-SESTA and the removal of Backpage on sex workers by Blunt, Danielle, Wolf, Ariel

    Published in Anti-trafficking review (01-04-2020)
    “…This short article presents in brief the findings of a community-based, sex worker-led survey that asked sex workers about their experiences since the closure…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects by Smyth, Liam, Blunt, Danielle N., Gatov, Evgenia, Nagamuthu, Chenthila, Croxford, Ruth, Mozessohn, Lee, Cheung, Matthew C.

    Published in British journal of haematology (01-11-2020)
    “…Summary Preclinical data suggests anti‐lymphoma potential for statins, metformin and cyclooxygenase‐2 (COX‐2) inhibitors. We performed a retrospective…”
    Get full text
    Journal Article
  4. 4

    Disabled Sex Workers’ Fight for Digital Rights, Platform Accessibility, and Design Justice by Coombes, Emily, Wolf, Ariel, Blunt, Danielle, Sparks, Kassandra

    Published in Disability studies quarterly (31-10-2022)
    “…Internet technologies are an increasingly necessary tool for sex working people, disabled people, and people who hold both identities to access resources,…”
    Get full text
    Journal Article
  5. 5

    Dramatic radiotherapy response in a necrotic lymphoma mass: a case report by McNeil, Nicholas, Gorayski, Peter, Blunt, Danielle, Roos, Daniel

    Published in Journal of medical case reports (28-07-2020)
    “…Diffuse large B-cell lymphoma (DLBCL) represents the most common form of non-Hodgkin lymphoma and is characterized by an aggressive natural history. It often…”
    Get full text
    Journal Article
  6. 6

    Rosai-Dorfman Disease: Rare Pulmonary Involvement Mimicking Pulmonary Langerhans Cell Histiocytosis and Review of the Literature by Cheung, Matthew C., Hana, Wedad, Blunt, Danielle, AL Umairi, Rashid, Oikonomou, Anastasia

    Published in Case reports in radiology (2018)
    “…Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare nonmalignant lymphohistiocytic proliferative disorder…”
    Get full text
    Journal Article
  7. 7

    Erased: The impact of FOSTA-SESTA and the removal of Backpage on sex workers by Blunt, Danielle, Wolf, Ariel

    Published in Anti-trafficking review (01-04-2020)
    “…A few days after Backpage was shut down by US federal authorities in April 2018, Public Law 115-164, better known as FOSTA-SESTA, became US law. Its stated…”
    Get full text
    Journal Article
  8. 8

    Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study by Smyth, Liam, Blunt, Danielle N., Gatov, Evgenia, Nagamuthu, Chenthila, Croxford, Ruth, Mozessohn, Lee, Cheung, Matthew

    Published in Blood (13-11-2019)
    “…Background: In the era of chemo-immunotherapy, risk factors associated with survival in patients with diffuse large B-cell lymphoma (DLBCL) are largely limited…”
    Get full text
    Journal Article
  9. 9

    Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study by Vijenthira, Abi, Mozessohn, Lee, Nagamuthu, Chenthila, Liu, Ning, Blunt, Danielle, Alibhai, Shabbir, Prica, Anca, Cheung, Matthew C.

    Published in Blood (05-11-2020)
    “…Introduction: Previous studies have demonstrated that frailty is associated with mortality among patients with non-Hodgkin lymphoma including diffuse large…”
    Get full text
    Journal Article
  10. 10

    Diagnosis to Treatment Interval in DLBCL Is Predictive of Overall Survival in a Large, Population-Based Registry by Blunt, Danielle N., Smyth, Liam, Gatov, Evgenia, Nagamuthu, Chenthila, Buckstein, Rena, Croxford, Ruth, Cheung, Matthew

    Published in Blood (29-11-2018)
    “…Despite advances in treatment for diffuse large B cell lymphoma (DLBCL), approximately one third of patients will relapse, with known risk factors largely…”
    Get full text
    Journal Article
  11. 11

    Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma by Vijenthira, Abi, Calzavara, Andrew, Nagamuthu, Chenthila, Kaliwal, Yosuf, Liu, Ning, Blunt, Danielle, Alibhai, Shabbir, Prica, Anca, Cheung, Matthew C., Mozessohn, Lee

    Published in Blood advances (10-09-2024)
    “…•Health care utilization and costs of older frail and nonfrail patients with DLBCL were described from initial treatment to end-of-life.•Frailty was associated…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14